GE HealthCare to buy Sofie Biosciences for $945M
GE HealthCare will pay $945 million in cash to acquire Sofie Biosciences and expand its radiopharmaceutical business.
Palanor Wire · composed from 3 outlets · every claim links to its sources
What happened
GE HealthCare Technologies agreed to acquire Sofie Biosciences for $945 million in cash. 123 GE HealthCare announced the acquisition on October 5, 2026. 3
Why it matters
The deal will expand GE HealthCare's radiopharmaceutical capabilities. 12 Sofie Biosciences develops time-sensitive drugs used in PET imaging. 1
Sources · 3
[1]GE HealthCare to buy Sofie Biosciences for $945 million to strengthen radiopharma business reut.rs/4hIAoVc
Reuters · Bluesky
[2]GE HealthCare Technologies (GEHC) to Acquire Sofie Biosciences for $945 Million
gurufocus.com · via Marketaux
[3]GE HealthCare to acquire Sofie Biosciences for $945M
BioPharma Dive
Matched signals
Lattice signals Numen pinned to this story at publish time.
No matched signals on this story.
Unlock the analytical widgets on every article — signal matches, Trends snapshots, X overlays, agent reasoning — with a Member account.
Upgrade →On X right now
Top engagement posts about this topic, ranked by likes + retweets + quotes.
No high-engagement X posts captured for this topic. Either the topic is too quiet or the upstream API was unavailable when this article published.
Unlock the analytical widgets on every article — signal matches, Trends snapshots, X overlays, agent reasoning — with a Member account.
Upgrade →Your read
How did this article land?
Three sliders. Optional comment. Anonymous is fine.
Open to anyone. One response per reader.